ALPS Medical Breakthroughs ETF
Price through Oct 22, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Oct 22, 2026. Holdings snapshot retrieved Oct 22, 2026.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
SBIO price
Table
| Date | SBIO close |
|---|---|
| Sep 22, 2026 | $63.35 |
| Sep 23, 2026 | $59.85 |
| Sep 24, 2026 | $58.55 |
| Sep 25, 2026 | $57.56 |
| Sep 28, 2026 | $57.93 |
| Sep 29, 2026 | $57.94 |
| Sep 30, 2026 | $58.30 |
| Oct 1, 2026 | $56.64 |
| Oct 2, 2026 | $56.15 |
| Oct 5, 2026 | $56.26 |
| Oct 6, 2026 | $54.38 |
| Oct 7, 2026 | $54.13 |
| Oct 8, 2026 | $53.95 |
| Oct 9, 2026 | $55.04 |
| Oct 12, 2026 | $53.85 |
| Oct 13, 2026 | $51.64 |
| Oct 14, 2026 | $51.20 |
| Oct 15, 2026 | $52.22 |
| Oct 16, 2026 | $50.12 |
| Oct 19, 2026 | $52.11 |
| Oct 20, 2026 | $54.81 |
| Oct 21, 2026 | $54.57 |
| Oct 22, 2026 | $54.55 |
Recent fund-flow records are unavailable, while the price has returned +6.5% so far this year. At 0.50% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
Sector weights
- Healthcare100%
- Health Technology97.84%
- Other4.16%
- Health Services2.19%
- Mutual fund0.07%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 97.84% |
| Other | 4.16% |
| Health Services | 2.19% |
| Mutual fund | 0.07% |
Country weights
- United States84.79%
- Netherlands4.21%
- United Kingdom3%
- Switzerland2.26%
- Canada2.18%
- France1.54%
- China1.21%
- Belgium1.19%
Show as table
| Item | Value (%) |
|---|---|
| United States | 84.79% |
| Netherlands | 4.21% |
| United Kingdom | 3% |
| Switzerland | 2.26% |
| Canada | 2.18% |
| France | 1.54% |
| China | 1.21% |
| Belgium | 1.19% |
| 1 week | +8.8% |
| 1 month | -13.9% |
| 3 months | -14.9% |
| 6 months | -3.9% |
| YTD | +6.5% |
| 1 year | +29.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat SBIO on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.2B | +$609M | -47bp on fee · 361× the assets · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -47bp on fee · 161× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -46bp on fee · 284× the assets · +$497M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -46bp on fee · 163× the assets · +$412M in over the month | Head-to-head |
| IEFA iShares Core MSCI EAFE ETF | 0.07% | $191B | +$817M | -43bp on fee · 1674× the assets · +$817M in over the month | Head-to-head |